ﺻﺮﻓﻪﺟﻮﻳﻲ ﺍﺭﺯﻱ 006ﻣﻴﻠﻴﻮﻥ ﺩﻻﺭﻱ ﺑﺎ ﺗﻮﻟﻴﺪ ﺩﺍﺭﻭﻫﺎﻱ ﺯﻳﺴﺘﻲ

SMTnewspaper - - ﺷﻬﺮ ﻭ ﺟﺎﻣﻌﻪ -

ﺭﻳﻴﺲ ﻛﺎﺭﮔﺮﻭﻩ ﺗﺠﻬﻴﺰﺍﺕ ﺯﻳﺴﺖ ﻓﻨﺎﻭﺭﻱ ﺳﺘﺎﺩ ﺗﻮﺳﻌﻪ ﺯﻳﺴــﺖ ﻓﻨﺎﻭﺭﻱ ﻣﻌﺎﻭﻧﺖ ﻋﻠﻤﻲ ﮔﻔﺖ: ﺩﺭ ﺗﻮﻟﻴﺪ ﺩﺍﺧﻠﻲ ﺩﺍﺭﻭﻫﺎﻱ ﺯﻳﺴﺘﻲ ﺭﺷﺪ ﺧﻮﺑﻲ ﺩﺍﺭﻳﻢ ﻭ ﻫﻤﻴﻦ ﺑﺎﻋﺚ ﺷﺪﻩ ﻛﻪ ﺩﺭ ﺣﺪﻭﺩ 006ﻣﻴﻠﻴﻮﻥ ﺩﻻﺭ ﺻﺮﻓﻪﺟﻮﻳﻲ ﺍﺭﺯﻱ ﺩﺍﺷﺘﻪ ﺑﺎﺷﻴﻢ.

ﺑــﻪ ﮔﺰﺍﺭﺵ ﻣﻬــﺮ، ﻣﻨﻮﭼﻬــﺮ ﻭﺛﻮﻗﻲ ﺍﻇﻬﺎﺭ ﻛــﺮﺩ: ﺩﺭ ﮔﺰﺍﺭﺷــﻲ ﻛﻪ ﺍﻧﻜﺘﺎﺩ ﺍﺯ ﻭﺿﻌﻴﺖ ﺯﻳﺴــﺖ ﻓﻨــﺎﻭﺭﻱ ﺍﻳﺮﺍﻥ ﺗﻬﻴــﻪ ﻛﺮﺩﻩ ﺁﻣﺪﻩ ﺍﺳــﺖ ﻛــﻪ ﺍﻳﺮﺍﻥ ﻧﺨﺴــﺘﻴﻦ ﺭﺗﺒﻪ ﺩﺭ ﺗﻮﻟﻴﺪ ﻭﺍﻛﺴﻦ ﺩﺭ ﻏﺮﺏ ﺍﺳــﻴﺎ ﺭﺍ ﺑﻪ ﺧﻮﺩ ﺍﺧﺘﺼﺎﺹ ﺩﺍﺩﻩ ﺍﺳﺖ.

ﻭﻱ ﺑــﺎ ﺑﻴﺎﻥ ﺍﻳﻨﻜﻪ ﻫﻤﭽﻨﻴﻦ ﺍﻳﺮﺍﻥ ﺩﺭ ﻣﻴﺎﻥ 5ﻛﺸــﻮﺭ ﻧﺨﺴــﺖ ﺩﺭ ﺯﻣﻴﻨــﻪ ﺗﻮﻟﻴﺪ ﻣﺤﺼﻮﻻﺕ ﺯﻳﺴــﺖ ﻓﻨﺎﻭﺭﻱ ﺍﺳﺖ، ﺧﺎﻃﺮﻧﺸﺎﻥ ﻛﺮﺩ: ﺍﻛﻨﻮﻥ ﺍﺭﺯﺵ ﻣﺤﺼﻮﻻﺕ ﺯﻳﺴﺖ ﻓﻨﺎﻭﺭﻱ 5/0ﻣﻴﻠﻴﺎﺭﺩ ﺩﻻﺭ ﺗﺨﻤﻴﻦﺯﺩﻩ ﺷﺪﻩ ﺍﺳﺖ.

ﻭﺛﻮﻗــﻲ ﺑﺎ ﺑﻴﺎﻥ ﺍﻳﻨﻜﻪ ﻫﻤﭽﻨﻴﻦ ﺍﻳﺮﺍﻥ ﺩﺭ ﺯﻣﻴﻨﻪ ﺗﻮﻟﻴﺪ ﺩﺍﺭﻭﻫﺎﻱ ﺯﻳﺴﺖ ﻓﻨﺎﻭﺭﻱ ﺭﺷﺪ ﭼﺸﻤﮕﻴﺮﻱ ﺩﺍﺷﺘﻪ ﺍﺳﺖ، ﻋﻨﻮﺍﻥ ﻛﺮﺩ: ﺩﺭ ﺑﺨﺶ ﺩﺍﺭﻭﻫﺎﻱ ﺯﻳﺴــﺖ ﻓﻨﺎﻭﺭﻱ ﺭﺷــﺪ ﺧﻮﺑﻲ ﺩﺍﺷــﺘﻴﻢ ﺑﻪ ﻃﻮﺭﻱﻛﻪ ﺳﺎﻻﻧﻪ ﺣﺪﻭﺩ 006ﻣﻴﻠﻴﻮﻥ ﺩﻻﺭ ﺻﺮﻓﻪﺟﻮﻳﻲ ﺍﺭﺯﻱ ﺩﺍﺭﻳﻢ.

ﺑــﻪ ﮔﻔﺘــﻪ ﻭﻱ، ﺩﺭ ﺍﻳــﻦ ﻣﺴــﻴﺮ ﺑــﺎ ﺳــﺮﻋﺖ ﺯﻳﺎﺩﻱ ﭘﮋﻭﻫﺸــﮕﺮﺍﻥ ﻛﺸــﻮﺭ ﺗﻮﺍﻧﺴــﺘﻪﺍﻧﺪ 21ﺩﺍﺭﻭ ﺭﺍ ﺑﻪ ﺗﻮﻟﻴﺪ ﺑﺮﺳﺎﻧﻨﺪ ﻛﻪ ﺍﻳﻦ ﺩﺍﺭﻭﻫﺎ ﺍﻛﻨﻮﻥ ﺩﺭ ﺑﺎﺯﺍﺭ ﻫﺴﺘﻨﺪ.

ﻭﻱ ﺑﺎ ﺗﺎﻛﻴﺪ ﺑﺮ ﺍﻳﻨﻜﻪ ﺍﻛﻨﻮﻥ ﺳــﺘﺎﺩ ﺯﻳﺴــﺖ ﻓﻨﺎﻭﺭﻱ ﻭ ﻭﺯﺍﺭﺕ ﺑﻬﺪﺍﺷــﺖ ﺗﻤــﺎﻡ ﺩﺍﺭﻭﻫﺎﻱ ﻭﺍﺭﺩﺍﺗﻲ ﺯﻳﺴــﺘﻲ ﺭﺍ ﺗﻌﻴﻴﻦ ﺗﻜﻠﻴﻒ ﻛﺮﺩﻩﺍﻧﺪ، ﺍﻓﺰﻭﺩ: ﺑﻪﻃﻮﺭ ﺗﻘﺮﻳﺒﻲ ﺗﻮﻟﻴﺪ ﻫﻤﻪ ﺩﺍﺭﻭﻫﺎﻱ ﺯﻳﺴﺘﻲ ﻭﺍﺭﺩﺍﺗﻲ ﭘﺮﻭژﻩ ﺷﺪﻩﺍﻧﺪ ﻭ ﺑﺎ ﺳﺮﻋﺖ ﺑﺎﻻ ﺩﺭ ﻣﺴﻴﺮ ﺗﻮﻟﻴﺪ ﻭ ﻭﺭﻭﺩ ﺑﻪ ﺑﺎﺯﺍﺭ ﻫﺴﺘﻨﺪ.

ﺭﻳﻴﺲ ﻛﺎﺭﮔﺮﻭﻩ ﺗﺠﻬﻴﺰﺍﺕ ﺯﻳﺴﺖ ﻓﻨﺎﻭﺭﻱ ﺳﺘﺎﺩ ﺗﻮﺳﻌﻪ ﺯﻳﺴﺖ ﻓﻨﺎﻭﺭﻱ ﻣﻌﺎﻭﻧﺖ ﻋﻠﻤﻲ ﺍﻓﺰﻭﺩ: ﺗﺎﻛﻨﻮﻥ ﺳﺎﻟﻲ ﻳﻚ ﻳﺎ 2ﺩﺍﺭﻭﻱ ﺯﻳﺴــﺘﻲ ﻭﺍﺭﺩ ﺑﺎﺯﺍﺭ ﻣﻲﺷــﺪﻩ ﻭﻟﻲ ﺍﻛﻨﻮﻥ ﺑﻪ ﻣﺮﺣﻠــﻪﺍﻱ ﺍﺯ ﭘﻴﺸــﺮﻓﺖ ﺭﺳــﻴﺪﻩﺍﻳﻢ ﻛﻪ ﺷــﺮﻛﺖﻫﺎﻱ ﺩﺍﻧﺶﺑﻨﻴﺎﻥ ﺩﺭ ﺁﻳﻨﺪﻩ ﻧﺰﺩﻳﻚ 4 ﺗﺎ 5ﺩﺍﺭﻭ ﺩﺭ ﺳــﺎﻝ ﺗﻮﻟﻴﺪ ﻭ ﺭﻭﺍﻧﻪ ﺑﺎﺯﺍﺭ ﻛﻨﻨﺪ.

Newspapers in Persian

Newspapers from Iran

© PressReader. All rights reserved.